Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02952989
Title A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seattle Genetics, Inc.
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
City of Hope National Medical Center Duarte California 91010-3000 United States Details
University of Colorado Hospital / University of Colorado Aurora Colorado 80045-0510 United States Details
Winship Cancer Institute / Emory University School of Medicine Atlanta Georgia 30322 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Karmanos Cancer Institute / Wayne State University Detroit Michigan 48201 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Providence Portland Medical Center Portland Oregon 97213 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center / University of Texas Houston Texas 77030-4095 United States Details
Seattle Cancer Care Alliance / University of Washington Seattle Washington 98109-1023 United States Details
*Shaded cells indicate that there was no data available from for the field